Belite Bio (BLTE) Tops Q1 EPS by 10c

Belite Bio (NASDAQ: BLTE) reported Q1 EPS of ($0.27), $0.10 better than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Belite Bio (BLTE) click here.

You May Also Be Interested In

• Solstice acquiring Element Solutions in $14.5B cash and stock deal
• SharkNinja (SN) PT Raised to $175 at Guggenheim
• Raymond James cuts Delta and JetBlue ratings ahead of Q2 earnings